114 related articles for article (PubMed ID: 323427)
1. Interstitial gamma irradiation by 198Au of the pituitary in diabetic retinopathy. Selective growth hormone blockade and ocular results.
Schaub C; Szikla G; Drouin P; Bleut-Pajot MT; Mejean L; Debry G; Talairach J
J Neurosurg; 1977 Jun; 46(6):703-16. PubMed ID: 323427
[TBL] [Abstract][Full Text] [Related]
2. [Indications and results of interstitial hypophyseal stereo-gammatherapy in the treatment of diabetic retinopathy].
Debry G; Schaub C; Drouin P; Szikla G; Talairach J
Neurochirurgie; 1977 Mar; 23(1):3-20. PubMed ID: 339116
[TBL] [Abstract][Full Text] [Related]
3. Computer analysis of ocular results following selective blockade of growth-hormone in diabetic retinopathy. A collaborative study.
Schaub C; Boujard O; Brouard N; Drouin P; Le Devehat C; Lemoine A; Mejean L; Mounier F; Regnault F; Saudax A
Metab Ophthalmol; 1984-1985; 8(1):35-42. PubMed ID: 6394947
[TBL] [Abstract][Full Text] [Related]
4. [Stereotaxic pituitary implantation of radio-gold in the treatment of severe diabetic retinopathy. Long term results (author's transl)].
Mirouze J; Schmouker Y; Cartry E
Nouv Presse Med; 1980 Mar; 9(10):687-91. PubMed ID: 6990381
[TBL] [Abstract][Full Text] [Related]
5. Hypophysectomy in diabetic retinopathy. The relationship between the degree of pituitary ablation and ocular response.
Adams DA; Rand RW; Roth NH; Dashe AM; Gipstein RM; Heuser G
Diabetes; 1974 Aug; 23(8):698-707. PubMed ID: 4604549
[No Abstract] [Full Text] [Related]
6. [In hibitory interstitial irradiation of the hypophysis in diabetic retinopathy].
Soulairac A; Talairach J; Schaub C; Aymard N; Franchimont P; Szikla G
Ann Endocrinol (Paris); 1969; 30(3):404-6. PubMed ID: 4902175
[No Abstract] [Full Text] [Related]
7. [Stereotaxic hypophyseal implantation of Au198 and diabetic retinopathy. 52 cases].
Cordier J; Debry G; Saudax E; Drouin P; Raspiller A
Bull Soc Ophtalmol Fr; 1979; 79(8-9):733-5. PubMed ID: 400236
[No Abstract] [Full Text] [Related]
8. [Trial treatment of diabetic retinopathy by inhibition of pituitary somatotropin secretion with MAP].
Bruni B; Bruni-Bocher K; Della Valle A; Gamba S
Minerva Med; 1975 Mar; 66(21):1001-23. PubMed ID: 1124148
[TBL] [Abstract][Full Text] [Related]
9. [[Stereo GIHF-indications in failure of treatment of proliferative diabetic retinopathy by pan retinal photocoagulation].
Constantinides G; Van-Hullebusch A; Lenski C; Schaub C
Bull Soc Ophtalmol Fr; 1982 Apr; 82(4):603-4. PubMed ID: 6179648
[No Abstract] [Full Text] [Related]
10. [Diabetic retinopathy: therapy aimed at the pituitary. Pituitary suppression interstitial stereogammatherapy].
Ardouin M; Urvoy M; Baudet D
Bull Soc Ophtalmol Fr; 1982 Dec; 82(12):1535-8. PubMed ID: 6764155
[No Abstract] [Full Text] [Related]
11. [Pituitary suppression interstitial stereogammatherapy and diabetic retinopathy. A critical study of the ophthalmic results based on 28 cases].
Baudet D; Urvoy M; Ardouin M; Hommay MT; Pecker J; Scarabin JM; Allanic H; Lereun M; Hespel JP
Bull Soc Ophtalmol Fr; 1982 Dec; 82(12):1543-6. PubMed ID: 6764157
[No Abstract] [Full Text] [Related]
12. Cryoablation of the pituitary in the treatment of progressive diabetic retinopathy.
Adams DA; Rand RW; Roth NH; Dashe AM; Heuser G; Hanley J; Parker M
Diabetes; 1968 Oct; 17(10):634-40. PubMed ID: 4878654
[No Abstract] [Full Text] [Related]
13. Serum growth hormone levels and the response of diabetic retinopathy to pituitary ablation.
Wright AD; Kohner EM; Oakley NW; Hartog M; Joplin GF; Fraser TR
Br Med J; 1969 May; 2(5653):346-8. PubMed ID: 5768460
[TBL] [Abstract][Full Text] [Related]
14. Pituitary ablation, insulin dosage, and course of diabetic retinopathy.
Danowski TS; Sabeh G; Alley RA; Robbins TJ; Sarver ME; Parsons JA; Susen AF; Narduzzi JV
Metabolism; 1968 Nov; 17(11):953-65. PubMed ID: 4177681
[No Abstract] [Full Text] [Related]
15. [Treatment of diabetic retinopathy by stereotaxic intrapituitary implantation of radioactive gold].
Debry G; Drouin P; Mejean L; Saudax E; Groboteck M; Talairach J; Schaub C; Szikla G; Bluet-Pajot MT; Nassiet J
Rev Prat; 1974 Jun; 24(35):3123-4 passim. PubMed ID: 4610696
[No Abstract] [Full Text] [Related]
16. [Indications for suppressive pituitary interstitial stereogammatherapy in diabetic retinopathy].
Constantinides G; Vanhullebusch A; Jounda M; Lenski C
Bull Soc Ophtalmol Fr; 1985 Feb; 85(2):195-8. PubMed ID: 3910291
[No Abstract] [Full Text] [Related]
17. Bragg peak proton beam irradiation of the pituitary gland for proliferative diabetic retinopathy.
Munichoodappa CS; Rees SB; Bradley RF; Balodimos MC; Boden G
Ann Intern Med; 1971 Apr; 74(4):491-8. PubMed ID: 5551157
[No Abstract] [Full Text] [Related]
18. [Effect of x-ray irradiation of the pituitary in the treatment of diabetic retinopathy].
KAHAN A; SZUCS Z; CSAPO G; OVENYI E
Szemeszet; 1962 Sep; 99():129-34. PubMed ID: 14453087
[No Abstract] [Full Text] [Related]
19. Growth hormone and diabetes mellitus. A review of sixty-three years of medical research and a glimpse into the future?
Sönksen PH; Russell-Jones D; Jones RH
Horm Res; 1993; 40(1-3):68-79. PubMed ID: 8300053
[TBL] [Abstract][Full Text] [Related]
20. PHYSIOLOGICAL AND PATHOLOGICAL ROLES OF GROWTH HORMONE.
HARTOG M
Postgrad Med J; 1964 Aug; 40(466):470-8. PubMed ID: 14184231
[No Abstract] [Full Text] [Related]
[Next] [New Search]
